Does GOLIMUMAB Cause Product dose omission issue? 4,216 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,216 reports of Product dose omission issue have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 6.1% of all adverse event reports for GOLIMUMAB.
4,216
Reports of Product dose omission issue with GOLIMUMAB
6.1%
of all GOLIMUMAB reports
10
Deaths
260
Hospitalizations
How Dangerous Is Product dose omission issue From GOLIMUMAB?
Of the 4,216 reports, 10 (0.2%) resulted in death, 260 (6.2%) required hospitalization, and 6 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 4,216 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which GOLIMUMAB Alternatives Have Lower Product dose omission issue Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN